Showing results (171-180 of 194) with videos related to
Sort By:
Pageof 20
Nature Medicine|April 15, 2020
CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruptionJustin Harper, Shari Gordon, Chi Ngai Chan, et al.Plos Pathogens|August 22, 2024
Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistenceBenjamin Varco-Merth, Morgan Chaunzwa, Derick M Duell, et al.Nature|February 5, 2020
Author Correction: Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cellsJulia Bergild McBrien, Maud Mavigner, Lavinia Franchitti, et al.Immunity|April 21, 2022
Combined protein and nucleic acid imaging reveals virus-dependent B cell and macrophage immunosuppression of tissue microenvironmentsSizun Jiang, Chi Ngai Chan, Xavier Rovira-Clavé, et al.Plos Pathogens|September 4, 2020
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challengeKier Om, Dominic Paquin-Proulx, Maria Montero, et al.Science Immunology|June 17, 2022
Myeloid cell tropism enables MHC-E-restricted CD8+ T cell priming and vaccine efficacy by the RhCMV/SIV vaccineScott G Hansen, Meaghan H Hancock, Daniel Malouli, et al.Nature Microbiology|January 30, 2026
Initial sites of SIV rebound after antiretroviral treatment cessation in rhesus macaquesBrandon F Keele, Afam A Okoye, Taina T Immonen, et al.Nature Immunology|September 12, 2024
Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruptionSusan Pereira Ribeiro, Zachary Strongin, Hugo Soudeyns, et al.Journal of Virology|February 4, 2021
Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity Ex Vivo and In VivoAndrea Gramatica, Roland Schwarzer, William Brantley, et al.Science Translational Medicine|January 20, 2017
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodiesConstantinos Petrovas, Sara Ferrando-Martinez, Michael Y Gerner, et al.Pageof 20